Pawel Marcin Wisniewski

Director/Board Member presso PURE BIOLOGICS S.A.

44 anni

Health Technology

Profilo

Pawel Marcin Wisniewski is currently serving as the Vice Chairman-Management Board at Helix Immuno-Oncology SA. He is also the Deputy Chairman-Supervisory Board at Pure Biologics SA and the Vice President-Management Board at 4cell Therapies SA. Previously, he held the position of Chief Executive Officer at Helix Polska Sp zoo and worked as a Project Manager at Adiuvo Investments SA from 2012 to 2016.

Posizioni attive di Pawel Marcin Wisniewski

Società	Posizione	Inizio
PURE BIOLOGICS S.A.	Director/Board Member	26/05/2023
Helix Immuno-Oncology SA Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland.	Corporate Officer/Principal	-

Tutte le posizioni attive di Pawel Marcin Wisniewski

Precedenti posizioni note di Pawel Marcin Wisniewski

Società	Posizione	Fine
Helix Polska Sp zoo Helix Polska Sp zoo Pharmaceuticals: MajorHealth Technology Helix Polska Sp zoo develops therapeutic products. The company is based in Warsaw, Poland.	Chief Executive Officer	-

Vedi nel dettaglio l'esperienza di Pawel Marcin Wisniewski

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Pawel Marcin Wisniewski

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
PURE BIOLOGICS S.A.	Health Technology

Aziende private	2
Helix Polska Sp zoo Helix Polska Sp zoo Pharmaceuticals: MajorHealth Technology Helix Polska Sp zoo develops therapeutic products. The company is based in Warsaw, Poland.	Health Technology
Helix Immuno-Oncology SA Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland.	Health Technology

Vedi le connessioni aziendali